← Back to Search

Biological

Platelet-rich plasma for Nail Diseases

Phase 4
Waitlist Available
Led By Shari R Lipner, MD, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, 4 weeks, 8 weeks, 12 weeks and 16 weeks
Awards & highlights

Study Summary

This trial will test whether platelet-rich plasma therapy can improve the appearance of nails in people with brittle nail syndrome.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, 4 weeks, 8 weeks, 12 weeks and 16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 4 weeks, 8 weeks, 12 weeks and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean change from baseline until week 16 of follow up using the Physician Global Improvement Assessment of the 8 target nails
Secondary outcome measures
Subject-reported assessment of nail health with a patient satisfaction survey administered at baseline and week 16.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Platelet-rich plasmaExperimental Treatment1 Intervention
The proximal nail fold is cleansed with alcohol and platelet-rich plasma obtained from the patient is injected using a 1ml syringe and 30g needle, 0.1-0.2 ml of platelet-rich plasma is injected into 8 proximal nail folds.
Group II: Platelet-poor plasmaPlacebo Group1 Intervention
The proximal nail fold is cleansed with alcohol and platelet-poor plasma obtained from the patient is injected using a 1ml syringe and 30g needle, 0.1-0.2 ml of platelet-poor plasma is injected into 2 proximal nail folds.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Platelet-rich plasma
2016
Completed Phase 4
~290

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,054 Previous Clinical Trials
1,316,518 Total Patients Enrolled
4 Trials studying Nail Diseases
31 Patients Enrolled for Nail Diseases
Eclipse Aesthetics, LLCOTHER
2 Previous Clinical Trials
70 Total Patients Enrolled
Shari R Lipner, MD, PhDPrincipal InvestigatorWeill Medical College of Cornell University
2 Previous Clinical Trials
2 Trials studying Nail Diseases

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new enrollees still being accepted for this research project?

"Affirmative. Clinicaltrials.gov provides evidence that the medical trial, which was posted on March 4th 2021, is actively recruiting volunteers. Ten people need to be enrolled at one site for this clinical study to proceed."

Answered by AI

How many participants are enrolled in this experimental trial?

"Affirmative. Clinicaltrials.gov has data which confirms that enrollment is presently open for this study, first posted on March 4th 2021 and edited most recently on July 19th 2022. The clinical trial seeks out 10 patients from a single location to participate."

Answered by AI

Is Platelet-rich plasma a secure therapeutic option for people?

"We assign a rating of 3 on the safety scale to Platelet-rich plasma due to its status as an approved treatment, denoting Phase 4 in this medical trial."

Answered by AI

Who else is applying?

What state do they live in?
Michigan
What site did they apply to?
Weill Cornell Medicine
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

What questions have other patients asked about this trial?

How long do I have to stay in New York?
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome
2021. "Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04941807.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top